Neurophysiology and Pharmacology of Cough Reflex Hypersensitivity
1 other identifier
interventional
24
1 country
1
Brief Summary
A cough lasting more than 2 months is known as a chronic cough, affecting 12-23% of the adult non-smoking population. Chronic cough has many associated complications including incontinence, muscular chest pains, blackouts and depression. Current treatment is often ineffective in these patients. To develop new medications the investigators need to understand more about the mechanisms that can lead to excessive coughing. This study plans to compare a group of 12 healthy volunteers and 12 patients with a chronic cough. The investigators hypothesise that that chronic cough patients have a more sensitive cough reflex as a result central nervous system hyper-excitability (central sensitisation). The investigators will measure cough reflex sensitivity before and after administration of ketamine, a medication that blocks an important receptor in the central nervous system.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2008
CompletedFirst Submitted
Initial submission to the registry
March 9, 2009
CompletedFirst Posted
Study publicly available on registry
March 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedJune 19, 2013
June 1, 2013
1.4 years
March 9, 2009
June 17, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cough Reflex Sensitivity
6 months
Secondary Outcomes (3)
Upper Oesophageal Pain Thresholds
6 months
Pain Thresholds Pharynx
6 months
Pain Thresholds Chest Wall
6 months
Study Arms (2)
Chronic Cough Patients
ACTIVE COMPARATORHealthy Volunteers
ACTIVE COMPARATORInterventions
Administration of low dose intravenous ketamine. Dose: 0.075mg/kg over 10 minutes followed by 0.005mg/kg/min over 20 minutes. Given as single infusion.
Eligibility Criteria
You may qualify if:
- Healthy Volunteers:
- Over 18 years old
- Measurable cough reflex sensitivity
- No current or past history of chronic cough or chronic respiratory disease.
- No symptoms of gastro-oesophageal reflux disease, asthma or post-nasal drip.
- Chronic Cough Patients
- Over 18 years old
- Chronic persistent cough (\> 8 weeks) despite investigation and/or treatment trials for cough variant asthma/post nasal drip and gastro-oesophageal reflux disease.
- Normal CXR
- Normal lung function
- Measurable cough reflex sensitivity
You may not qualify if:
- Recent Upper Respiratory Tract Infection (4 weeks)
- Pregnancy/breast feeding
- Current smokers or ex-smokers with \< 6 months abstinence or cumulative history of \> 10 packyears
- Diabetes Mellitus
- Opiate or ACE Inhibitor use.
- Any centrally acting medication which has the potential to alter cough reflex sensitivity.
- Significant and ongoing chronic respiratory, cardiovascular (in particular hypertension), gastro-intestinal, haematological (porphyria), neurological or psychiatric illness.
- Drug or alcohol abuse
- History of allergy or reaction to ketamine of other NMDA receptor antagonists.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jacky Smithlead
Study Sites (1)
University of Manchester, Education and Research Centre, Wythenshawe Hospital
Manchester, Manchester, M23 9LT, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Reader
Study Record Dates
First Submitted
March 9, 2009
First Posted
March 10, 2009
Study Start
February 1, 2008
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
June 19, 2013
Record last verified: 2013-06